Company Filing History:
Years Active: 2019-2020
Title: Innovations of Fengqing Wang in Steroidal Compound Production
Introduction
Fengqing Wang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the production of steroidal compounds. With a total of 2 patents, his work focuses on genetically-engineered strains that enhance the efficiency and quality of steroid drug production.
Latest Patents
Fengqing Wang's latest patents include a genetically-engineered mycobacterium strain and a use thereof in the preparation of steroidal compounds. This invention relates to a genetically-engineered strain that lacks acyl-CoA dehydrogenase genes fadE31, fadE32, and fadE33. The strain is designed to improve the production efficiency and product quality of steroid drugs while reducing energy consumption and production costs.
Another significant patent involves a hydroxyacyl-coenzyme A dehydrogenase gene and an acyl-coenzyme A thiolase gene. This invention constructs genetically engineered strains that are utilized in the preparation of various steroidal compounds. The advantages of this invention include improved utilization of drug precursors, environmentally friendly production processes, and high economic and social benefits.
Career Highlights
Fengqing Wang is affiliated with the East China University of Science and Technology, where he conducts research and development in biotechnology. His innovative approaches have garnered attention in the scientific community, contributing to advancements in steroid drug production.
Collaborations
Fengqing Wang collaborates with esteemed colleagues such as Dongzhi Wei and Liqin Xu. Their combined expertise enhances the research and development efforts in their field.
Conclusion
Fengqing Wang's contributions to the field of biotechnology, particularly in the production of steroidal compounds, demonstrate his innovative spirit and commitment to improving drug production processes. His patents reflect a significant advancement in the utilization of genetically-engineered strains, paving the way for more efficient and cost-effective pharmaceutical solutions.